Arkolith/Insider Trading/GANX/Form 4

Islam Khalid

Executive Chairman, DirectorGain Therapeutics, Inc. (GANX) · full profile →Form 4 · filed Aug 12, 2024
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 9, 2024Buy(P)50K$1.00$50K50K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-031377) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML